Given the significant differences in prognosis and treatment strategies between T-cell and B-cell lymphomas, accurately distinguishing CD20-positive PTCL from B-cell lymphoma is crucial. Here, MS4A1 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.